Therapeutic application of dysprosium-165-FHMA in the treatment of rheumatoid knee effusions
Journal Article
·
· J. Nucl. Med. Technol.; (United States)
OSTI ID:5957459
Radiation synovectomy utilizing a variety of radionuclides has proven to be an effective technique in the treatment of rheumatoid arthritis. The recent introduction of the short-lived radionuclide, Dysprosium-165 (/sup 165/Dy), as a replacement for the longer-lived radiocolloids has reduced nontarget dosimetry caused by leakage of the agent from the articular cavity. A review of the methods and status of radiation synovectomy, and the application of /sup 165/Dy-ferric hydroxide macroaggregates (FHMA) as an alternative therapeutic agent is described.
- Research Organization:
- Brigham and Women's Hospital, Boston, MA
- OSTI ID:
- 5957459
- Journal Information:
- J. Nucl. Med. Technol.; (United States), Journal Name: J. Nucl. Med. Technol.; (United States) Vol. 14:1; ISSN JNMTB
- Country of Publication:
- United States
- Language:
- English
Similar Records
Synovectomy of the rheumatoid knee using intra-articular injection of dysprosium-165-ferric hydroxide macroaggregates
Repeat radiation synovectomy with dysprosium 165-ferric hydroxide macroaggregates in rheumatoid knees unresponsive to initial injection
Treatment of rheumatoid synovitis of the knee with intraarticular injection of dysprosium 165-ferric hydroxide macroaggregates
Journal Article
·
Tue Sep 01 00:00:00 EDT 1987
· J. Bone Jt. Surg., Am. Vol.; (United States)
·
OSTI ID:5840582
Repeat radiation synovectomy with dysprosium 165-ferric hydroxide macroaggregates in rheumatoid knees unresponsive to initial injection
Journal Article
·
Wed Jun 01 00:00:00 EDT 1988
· Arthritis Rheum.; (United States)
·
OSTI ID:6971930
Treatment of rheumatoid synovitis of the knee with intraarticular injection of dysprosium 165-ferric hydroxide macroaggregates
Journal Article
·
Fri Jan 31 23:00:00 EST 1986
· Arthritis Rheum.; (United States)
·
OSTI ID:5737573
Related Subjects
550604* -- Medicine-- Unsealed Radionuclides in Therapy-- (1980-)
62 RADIOLOGY AND NUCLEAR MEDICINE
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
BONE JOINTS
CHEMICAL PROPERTIES
COLLOIDS
DAYS LIVING RADIOISOTOPES
DISEASES
DISPERSIONS
DRUGS
DYSPROSIUM 165
DYSPROSIUM ISOTOPES
ELECTRON CAPTURE RADIOISOTOPES
ERBIUM 169
ERBIUM ISOTOPES
EVEN-ODD NUCLEI
GOLD 198
GOLD ISOTOPES
HEAVY NUCLEI
HOURS LIVING RADIOISOTOPES
HYDROGEN COMPOUNDS
HYDROXIDES
INTERMEDIATE MASS NUCLEI
INTERNAL CONVERSION RADIOISOTOPES
IRON COMPOUNDS
IRON HYDROXIDES
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LABELLED COMPOUNDS
MEDICINE
NUCLEAR MEDICINE
NUCLEI
ODD-ODD NUCLEI
ORGANS
OXYGEN COMPOUNDS
RADIOCOLLOIDS
RADIOISOTOPES
RADIOLOGY
RADIOPHARMACEUTICALS
RADIOTHERAPY
RARE EARTH ISOTOPES
RARE EARTH NUCLEI
RHENIUM 186
RHENIUM ISOTOPES
RHEUMATIC DISEASES
SKELETAL DISEASES
SKELETON
THERAPY
TRANSITION ELEMENT COMPOUNDS
YTTRIUM 90
YTTRIUM ISOTOPES
62 RADIOLOGY AND NUCLEAR MEDICINE
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BODY
BONE JOINTS
CHEMICAL PROPERTIES
COLLOIDS
DAYS LIVING RADIOISOTOPES
DISEASES
DISPERSIONS
DRUGS
DYSPROSIUM 165
DYSPROSIUM ISOTOPES
ELECTRON CAPTURE RADIOISOTOPES
ERBIUM 169
ERBIUM ISOTOPES
EVEN-ODD NUCLEI
GOLD 198
GOLD ISOTOPES
HEAVY NUCLEI
HOURS LIVING RADIOISOTOPES
HYDROGEN COMPOUNDS
HYDROXIDES
INTERMEDIATE MASS NUCLEI
INTERNAL CONVERSION RADIOISOTOPES
IRON COMPOUNDS
IRON HYDROXIDES
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LABELLED COMPOUNDS
MEDICINE
NUCLEAR MEDICINE
NUCLEI
ODD-ODD NUCLEI
ORGANS
OXYGEN COMPOUNDS
RADIOCOLLOIDS
RADIOISOTOPES
RADIOLOGY
RADIOPHARMACEUTICALS
RADIOTHERAPY
RARE EARTH ISOTOPES
RARE EARTH NUCLEI
RHENIUM 186
RHENIUM ISOTOPES
RHEUMATIC DISEASES
SKELETAL DISEASES
SKELETON
THERAPY
TRANSITION ELEMENT COMPOUNDS
YTTRIUM 90
YTTRIUM ISOTOPES